NGAL release from peripheral blood mononuclear cells protects against acute kidney injury and prevents AKI induced fibrosis

We propose the use of a peripheral blood mononuclear cell therapy based on cell NGAL release to be used in the clinical setting for acute kidney injury (AKI) and the derived fibrosis. First, we designed a procedure whereby PBMC overexpress NGAL and anti-inflammatory agents when subjected to repetiti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2022-09, Vol.153, p.113415-113415, Article 113415
Hauptverfasser:	Játiva, Soraya, Torrico, Selene, Calle, Priscila, Muñoz, Ángeles, García, Miriam, Larque, Ana Belén, Poch, Esteban, Hotter, Georgina
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute kidney failure Inflammation Macrophage Monocyte NGAL
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!